Check out our most popular compounded medications! Get Started
The Estradiol 0.25 mg/Estriol 1 mg Oral Troche is a square-shaped solid dosage form intended for buccal administration. This compounded medication is specifically formulated to dissolve slowly in the mouth, allowing for the absorption of the active ingredients through the oral mucosa. This method of delivery is designed to provide either targeted local relief or systemic effects, depending on the clinical indication.
This particular formulation combines two estrogens, estradiol and estriol, in a single troche. Estradiol is a potent form of estrogen commonly used in hormone replacement therapy, while estriol is a weaker estrogen that is often used in combination with other estrogens. The dual-ingredient troche is utilized in the management of menopausal symptoms such as hot flashes, vaginal dryness, and osteoporosis prevention. Additionally, it may be prescribed for hormone imbalances or deficiencies in estrogen, and for conditions that benefit from estrogen therapy.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Estradiol 0.25 mg/Estriol 1 mg Oral Troche is a compounded medication specifically designed to deliver a combination of estrogen hormones directly through the oral mucosa. This square-shaped solid dosage form is intended to dissolve slowly in the mouth, allowing for the medication to be absorbed directly into the bloodstream, bypassing the gastrointestinal tract and first-pass metabolism in the liver. This method of delivery can provide a more consistent and efficient absorption of the hormones, potentially reducing the risk of gastrointestinal side effects and improving the bioavailability of the medication.
Estradiol and estriol are forms of estrogen, a hormone that plays a critical role in the regulation of many processes in the female body, including the menstrual cycle and reproductive system, as well as the maintenance of bone density and cardiovascular health. The combination of estradiol and estriol in this troche formulation is often used in hormone replacement therapy (HRT) for the management of menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and osteoporosis prevention. Additionally, it may be prescribed for conditions that cause estrogen deficiency or for transgender hormone therapy.
For patients, it is important to understand that this medication should be used under the guidance of a healthcare provider, as hormone therapy can be associated with certain risks and side effects. It is essential to follow the prescribed dosage and administration instructions to ensure optimal efficacy and safety. For prescribers, the tailored dosages of estradiol and estriol in this troche allow for a personalized approach to HRT, considering the individual patient's needs and hormone levels. Monitoring and regular follow-up are recommended to adjust the therapy as necessary and to evaluate the patient's response to treatment.
Bayview Pharmacy's team of compounding pharmacists is committed to providing high-quality, customized medications to meet the unique needs of each patient. If you have any questions about the Estradiol 0.25 mg/Estriol 1 mg Oral Troche or its use in treating specific disease states, please do not hesitate to reach out to us. We are here to support both patients and healthcare providers with expert advice and comprehensive care.
The estradiol 0.25 mg/estriol 1 mg oral troche is a compounded medication that combines two forms of estrogen, estradiol and estriol, in a square-shaped solid dosage form designed to dissolve slowly in the mouth. This allows for the medication to be absorbed through the oral mucosa, which can provide targeted local or systemic effects. This formulation is often used in hormone replacement therapy for the management of menopausal symptoms such as hot flashes, vaginal dryness, and osteoporosis prevention. It may also be used for other conditions as determined by a healthcare provider.
When considering the use of this estradiol/estriol oral troche, it is important to be aware of potential drug interactions that could affect the efficacy of the medication or increase the risk of adverse effects. Estrogens can interact with a variety of medications, including but not limited to thyroid hormones, anticoagulants, antidiabetic agents, and some herbal supplements. For example, concurrent use of estrogens with thyroid hormone replacement therapy may necessitate adjustments in the dose of thyroid medication due to changes in thyroid-binding globulin levels. Estrogens can also potentiate the effects of anticoagulant medications like warfarin, which may require closer monitoring of coagulation parameters and possible dose adjustments.
Additionally, estrogens may decrease the blood glucose-lowering effect of antidiabetic agents, which could necessitate a dosage adjustment of the antidiabetic medication to maintain glycemic control. Patients should also be cautious about using certain herbal supplements, such as St. John's Wort, which can induce hepatic enzymes and potentially reduce the effectiveness of estrogen therapy. It is also important to note that smoking can increase the metabolism of estrogens and reduce their clinical effects, as well as increase the risk of cardiovascular side effects.
Other medications that may interact with estrogens include some antihypertensive agents, corticosteroids, and certain types of antibiotics and antifungals. Patients should inform their healthcare provider of all medications, supplements, and over-the-counter drugs they are taking to ensure that any potential interactions can be managed appropriately. It is also important for prescribers to review the patient's medication history and to monitor for any signs of adverse reactions or changes in the efficacy of concurrent medications.
Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly. If you have any questions or concerns about the use of this estradiol/estriol oral troche or potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
The Estradiol 0.25 mg/Estriol 1 mg Oral Troche is a compounded medication that combines two forms of estrogen, estradiol and estriol, in a square-shaped solid dosage form. This troche is specifically designed to dissolve slowly in the mouth, which allows the medication to be absorbed directly through the oral mucosa. This method of delivery bypasses the gastrointestinal tract and first-pass metabolism in the liver, potentially reducing the risk of systemic side effects and improving the bioavailability of the hormones.
Estradiol is a potent form of estrogen and is identical to the hormone produced by the ovaries. It is responsible for the regulation of many processes in the body, including the menstrual cycle and reproductive system. Estriol, on the other hand, is a weaker estrogen that is produced in significant amounts during pregnancy. The combination of estradiol and estriol in this troche aims to provide a balanced hormone replacement therapy (HRT), which can be beneficial in treating various conditions associated with estrogen deficiency.
This formulation is commonly used in the management of menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and osteoporosis prevention. By delivering estrogens directly to the bloodstream through the oral mucosa, the troche can help restore hormonal balance and alleviate these symptoms. Additionally, because the troche is absorbed in the mouth, it may be a suitable option for patients who have difficulties swallowing pills or for those who prefer not to take medications orally.
It is important for both patients and prescribers to understand that hormone replacement therapy with estrogens should be tailored to the individual's needs and should be used at the lowest effective dose for the shortest duration consistent with treatment goals and risks for the individual woman. Patients with a history of hormone-sensitive cancers, thromboembolic disorders, or unexplained vaginal bleeding should not use this medication. Regular monitoring and follow-up with a healthcare provider are essential to ensure the safe and appropriate use of this HRT formulation.
For more detailed information about the Estradiol 0.25 mg/Estriol 1 mg Oral Troche, including its pharmacokinetics, potential side effects, contraindications, and monitoring parameters, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure optimal therapeutic outcomes for our patients and prescribers.
An Estradiol 0.25 mg/Estriol 1 mg Oral Troche is a square-shaped solid dosage form containing the hormones estradiol and estriol. It is designed to dissolve slowly in the mouth to allow for absorption of the medication through the oral mucosa, providing either localized or systemic therapeutic effects.
To use an oral troche, place the square-shaped troche in your mouth and allow it to dissolve slowly, usually between the gum and cheek. Do not chew or swallow the troche; proper absorption occurs through the mucosal tissue in your mouth.
The time it takes for the oral troche to dissolve can vary, but typically it should dissolve within 15 to 30 minutes. It's important to let it dissolve completely to ensure proper dosing and absorption.
The frequency at which you should take the Estradiol 0.25 mg/Estriol 1 mg Oral Troche should be determined by your healthcare provider. Follow the prescribed regimen exactly as directed.
It is generally recommended to avoid eating or drinking anything while the oral troche is dissolving and for a short period afterwards to ensure proper absorption. Your healthcare provider will give you specific instructions on how long to wait before eating or drinking.
If you miss a dose of your oral troche, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one without consulting your healthcare provider.
Like all medications, the oral troche can have side effects, which may include local irritation, nausea, headache, breast tenderness, or breakthrough bleeding. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Estradiol and estriol are hormones that can have effects on pregnancy and breastfeeding. This medication should not be used during pregnancy or breastfeeding unless specifically prescribed by your healthcare provider. Always consult with your provider before starting any new medication in these circumstances.
Store the oral troches at room temperature, away from moisture and heat. Keep them in their original packaging, and make sure they are out of reach of children and pets.
Yes, a prescription from a licensed healthcare provider is required to obtain Estradiol 0.25 mg/Estriol 1 mg Oral Troches. Do not use this medication without the guidance of your healthcare provider.
There are no specific restrictions on driving or operating heavy machinery after taking an Estradiol 0.25 mg/Estriol 1 mg Oral Troche. However, if you experience dizziness or any other side effect that could impair your ability to safely perform these activities, avoid them and consult your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
